MRI Assessment of Myocardial Fibrosis Associated With Monocyte Phenotype in End Stage Renal Failure
NCT03857633 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2021-10-08
Summary
Firstly, this study aims to understand how cardiac fibrosis mediated by inflammatory microvascular disease evolves during advanced chronic kidney disease and end stage renal failure and importantly how this changes with commencement on renal replacement therapy (haemodialysis and peritoneal dialysis) using sequential cardiac MRI imaging. This method of imaging is non-invasive, provides significantly more data than echocardiography, is reproducible and accurate, has been validated in numerous studies and does not involve exposure to ionising radiation.
Secondly, this study aims to examine the changes in monocyte subsets and biochemical profile in peripheral blood prior to, during and after commencement on renal replacement therapy.
The investigators hypothesis would be that renal failure causes alteration in monocyte subset phenotype resulting in increased circulating inflammatory monocytes (human CD14high CD16high), initiating pro-inflammatory cytokine expression and thereby accelerating inflammatory cardiovascular disease and development of myocardial fibrosis.
Conditions
- Myocardial Fibrosis
- End Stage Renal Failure on Dialysis
- Chronic Kidney Disease, Stage IV (Severe)
- Chronic Kidney Disease Stage V
- Heart Failure
Interventions
- DIAGNOSTIC_TEST
-
Cardiac MRI 1 - With Gadolinium Contrast
Cines for cardiac function and volumes, T2 myomaps, Resting perfusion and strain analysis, Tagging (strain), T1 myomaps, Late gadolinium enhancement During the MRI scan participants would be required perform a short period of low intensity exercise involving peddling on an adapted cycle for 10-15 minutes to provide additional data on cardiac function under exertion.
- DIAGNOSTIC_TEST
-
Cardiac MRI 2 - With Gadolinium Contrast
Cines for cardiac function and volumes, T2 myomaps, Resting perfusion and strain analysis, Tagging (strain), T1 myomaps, Late gadolinium enhancement During the MRI scan participants would be required perform a short period of low intensity exercise involving peddling on an adapted cycle for 10-15 minutes to provide additional data on cardiac function under exertion.
- DIAGNOSTIC_TEST
-
Cardiac MRI 3 - Without Gadolinium Contrast
Cines for cardiac function and volumes, T2 myomaps, Resting perfusion and strain analysis, Tagging (strain), T1 myomaps. During the MRI scan participants would be required perform a short period of low intensity exercise involving peddling on an adapted cycle for 10-15 minutes to provide additional data on cardiac function under exertion.
- DIAGNOSTIC_TEST
-
Cardiac MRI 3 - With Gadolinium Contrast
Cines for cardiac function and volumes, T2 myomaps, Resting perfusion and strain analysis, Tagging (strain), T1 myomaps, Late gadolinium enhancement During the MRI scan participants would be required perform a short period of low intensity exercise involving peddling on an adapted cycle for 10-15 minutes to provide additional data on cardiac function under exertion.
- DIAGNOSTIC_TEST
-
Peripheral Whole Blood Samples
20ml EDTA whole blood samples - collected sequentially during study - max 8 time points
Sponsors & Collaborators
-
National Institute for Health Research, United Kingdom
collaborator OTHER_GOV -
Imperial College Healthcare NHS Trust
collaborator OTHER -
Imperial College London
lead OTHER
Principal Investigators
-
Neill Duncan, MBBS FRCP · Imperial College Healthcare NHS Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-01
- Primary Completion
- 2021-02-01
- Completion
- 2021-02-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease
NCT02997046 ·Status: COMPLETED
-
Kidney Fibrosis and MRI
NCT03964948 ·Status: COMPLETED ·Phase: NA
-
MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal Artery
NCT00027469 ·Status: COMPLETED ·Phase: PHASE1
-
Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT06348524 ·Status: TERMINATED ·Phase: PHASE3
-
Multifrequency MRE in Evaluation of Chronic Kidney Diseases
NCT06202235 ·Status: RECRUITING
-
International T1 Multicentre CMR Outcome Study
NCT02407197 ·Status: COMPLETED
-
Multimodal Cardiovascular Magnetic Resonance Imaging for Cardiometabolic Pre-HF and HFpEF
NCT07336316 ·Status: ENROLLING_BY_INVITATION
-
⁶⁸Ga-FAPI PET/CT for Cardiac Fibrosis in Heart Failure
NCT07296081 ·Status: RECRUITING
-
Explore New Magnetic Resonance Technology in Assessment of Renal Dysfunction
NCT06366529 ·Status: RECRUITING
-
Phase Analysis and Obstructive CAD on Rubidium PET
NCT01840696 ·Status: WITHDRAWN ·Phase: PHASE2
-
Application of Functional Renal MRI to Improve Assessment of Chronic Kidney Disease
NCT04238299 ·Status: ACTIVE_NOT_RECRUITING
-
Vascular Endothelial Function and Cardiac Resynchronization Response in Patients With Heart Failure
NCT02783716 ·Status: TERMINATED ·Phase: NA
-
Routine vs Selective Cardiac Magnetic Resonance in Non-Ischemic Heart Failure
NCT01281384 ·Status: COMPLETED ·Phase: NA
-
Inflammatory Cell Trafficking After Myocardial Infarction
NCT01127113 ·Status: WITHDRAWN ·Phase: NA
-
CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF
NCT06316661 ·Status: RECRUITING
-
Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT02954510 ·Status: UNKNOWN ·Phase: PHASE3
-
Characterization of Myocardial Interstitial Fibrosis and Cardiomyocyte Hypertrophy by Cardiac MRI in Heart Failure
NCT03084679 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate Renal Fibrosis Using MRI Techniques
NCT04508049 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
NCT07083011 ·Status: RECRUITING ·Phase: PHASE2
-
Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Cardiac Transplant Rejection
NCT01136135 ·Status: COMPLETED
-
MRI Biomarkers in Diabetic Kidney Disease
NCT04570735 ·Status: COMPLETED
-
Renal Perfusion Assessment in the Endovascular Treatment of Renal Artery Stenosis
NCT05603221 ·Status: UNKNOWN
-
Non-invasive Quantification of Atrial Fibrosis by MRI in Atrial Fibrillation
NCT02885883 ·Status: COMPLETED ·Phase: NA
-
Validation of CMR Against Invasive Haemodynamics in Patients With HFpEF
NCT03251183 ·Status: COMPLETED
-
Developing Imaging And plasMa biOmarkers iN Describing Heart Failure With Preserved Ejection Fraction (DIAMONDHFpEF)
NCT03050593 ·Status: COMPLETED